Abstract
The most recent genome-wide association study of migraine increased the total number of known migraine risk loci to 38. Still, most of the heritability of migraine remains unexplained, and it has been suggested that rare gene dysregulatory variants play an important role in migraine etiology. Addressing the missing heritability of migraine, we aim to fine-map signals from the known migraine risk loci to regulatory mechanisms and associate these to downstream genic targets. We analyzed a large cohort of whole-genome sequenced patients from extended migraine pedigrees (1040 individuals from 155 families). We test for association between rare variants segregating in regulatory regions with migraine. The findings were replicated in an independent case-control cohort (2027 migraineurs, 1650 controls). We report an increased burden of rare variants in one CpG island and three polycomb group response elements near four migraine risk loci. We found that the association is independent of the common risk variants in the loci. The regulatory regions are suggested to affect different genes than those originally tagged by the index SNPs of the migraine loci. Families with familial clustering of migraine have an increased burden of rare variants in regulatory regions near known migraine risk loci, with effects that are independent of the variants in the loci. The possible regulatory targets suggest different genes than those originally tagged by the index SNPs of the migraine loci.
Highlights
Electronic supplementary material The online version of this article contains supplementary material, which is available to authorized users.Migraine is a debilitating and complex genetic disorder with 1 billion affected individuals worldwide and a life-time prevalence of 15–20% [1]
The possible regulatory targets suggest different genes than those originally tagged by the index SNPs of the migraine loci
We analyzed 155 migraine families (n = 1040) and 37 autosomal migraine risk loci and found a significant increased burden of rare variants segregating with migraine in 39 regulatory regions
Summary
Migraine is a debilitating and complex genetic disorder with 1 billion affected individuals worldwide and a life-time prevalence of 15–20% [1]. Migraine has a considerable social and economic impact, with annual expenses estimated at €27 billion in Europe alone [2]. The Global Burden of Disease Study (2016) ranks migraine the second highest cause of disability worldwide [3]. Rare variants with large effect sizes may be implicated with a high migraine risk [5]. The most recent meta-analysis on migraine genomewide association studies (GWAS) identified 44 independent SNPs defining 38 migraine risk loci [6]. A GWAS typically assesses common SNPs derived from imputation and genotyping, and effect sizes are small.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.